Cargando…
Integrating imaging and biomarker assessment to better define psoriatic arthritis and predict response to biologic therapy
The treatment options for PsA have substantially expanded over the last decade. Approximately 40% of patients will not respond to first-line anti-TNF-α therapies. There is limited data to help clinicians select the most appropriate biologic therapy for PsA patients, including guidance for decisions...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709569/ https://www.ncbi.nlm.nih.gov/pubmed/34951926 http://dx.doi.org/10.1093/rheumatology/keab504 |